Brief: Rhovac Publishes Research Results Prior Asco's Meeting
May 21 (Reuters) - RhoVac AB RHOVAC.TE :
* RHOVAC PUBLISHES RESEARCH RESULTS PRIOR ASCO'S MEETING
* RHOC IS EXPRESSED TO A GREATER EXTENT IN METASTATIC TISSUE
* THERE IS A SUBPOPULATION OF RHOC-POSITIVE CELLS IN
METASTASES,
WHICH ARE DOUBLE-LABELED WITH CD166 TO CANCER STEM CELLS
Source text for Eikon: ID:nWkr98Bc5M
Further company coverage: RHOVAC.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Chosa Oncology AB
See all newsBrief: Chosa Oncology Appoints Gerton Jönsson As New Chief Financial Officer
Brief: CHOSA Oncology AB Says Postpones Publication Of Interim Report Q4 2024
Brief: Chosa Oncology Carried Out Directed Issue Of Sek 1,55 Mln To Further Increase Business Development Activities
Brief: Chosa Oncology Announces Decision To Postpone Release Of Interim Report For Q2 2023
Brief: Chosa Oncology AB Publishes Results From Clinical Phase 2 Trial Of Liposomal Formulation In Breast Cancer, Using Predictive Marker For Cisplatin